High-Throughput Cellular Screening of Engineered Nuclease Activity Using the Single-Strand Annealing Assay and Luciferase Reporter

  • Thomas J. Cradick
  • Christopher J. Antico
  • Gang Bao
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 1114)

Abstract

Engineered nucleases have been used to generate many model organisms and show great promise for therapeutic genome editing. Current methods to evaluate the activity of these nucleases can be laborious and often are hampered by readouts with small signals and a significant amount of background noise. We present a simple method that utilizes the established single-strand annealing (SSA) assay coupled with a luciferase assay to generate a high-throughput analysis of nuclease activity. Luciferase reporters provide a higher signal and lower background levels than fluorescent reporters. We engineered a commercially available luciferase plasmid (pGL4.51, Promega) to generate a set of nuclease target plasmids that produce a high signal and activity that correlates well with in vitro data. The SSA luciferase assay can discriminate between nucleases that give similar signals with other nuclease activity assays. The target plasmid and nucleases are transfected into cells and are generally cultured for 2 days. Luciferase activity is quantified in the same cell culture plate—streamlining the process from transfection to assay. We have used this robust process to investigate the activity of zinc finger nucleases (ZFNs) and transcription activated-like effector nucleases (TALENs).

Key words

Engineered nucleases Zinc finger nuclease Transcription activated-like effector nuclease Luciferase Single-strand annealing 

References

  1. 1.
    Ruminy P, Derambure C, Chandrasegaran S, Salier JP (2001) Long-range identification of hepatocyte nuclear factor-3 (FoxA) high and low-affinity binding sites with a chimeric nuclease. J Mol Biol 310(3):523–535PubMedCrossRefGoogle Scholar
  2. 2.
    Mani M, Kandavelou K, Dy FJ, Durai S, Chandrasegaran S (2005) Design, engineering, and characterization of zinc finger nucleases. Biochem Biophys Res Commun 335(2):447–457PubMedCrossRefGoogle Scholar
  3. 3.
    Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S et al (2005) Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature 435(7042):646–651PubMedCrossRefGoogle Scholar
  4. 4.
    Cradick TJ, Keck K, Bradshaw S et al (2010) Zinc-finger nucleases as a novel therapeutic strategy for targeting hepatitis B virus DNAs. Mol Ther 18(5):947–954PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Szczepek M, Brondani V, Buchel J et al (2007) Structure-based redesign of the dimerization interface reduces the toxicity of zinc-finger nucleases. Nat Biotechnol 25(7):786–793PubMedCrossRefGoogle Scholar
  6. 6.
    Choy G, O’Connor S, Diehn FE et al (2003) Comparison of noninvasive fluorescent and bioluminescent small animal optical imaging. Biotechniques 35(5):1022–1030PubMedGoogle Scholar
  7. 7.
    Evans E, Sugawara N, Haber JE et al (2000) The Saccharomyces cerevisiae Msh2 mismatch repair protein localizes to recombination intermediates in vivo. Mol Cell 5(5):789–799PubMedCrossRefGoogle Scholar
  8. 8.
    Preston CR, Engels W, Flores C (2002) Efficient repair of DNA breaks in Drosophila: evidence for single-strand annealing and competition with other repair pathways. Genetics 161(2):711–720PubMedCentralPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2014

Authors and Affiliations

  • Thomas J. Cradick
    • 1
  • Christopher J. Antico
    • 1
  • Gang Bao
    • 1
  1. 1.Wallace H. Coulter Department of Biomedical EngineeringGeorgia Institute of TechnologyAtlantaUSA

Personalised recommendations